跳转至内容
Merck
CN

S8076

Sigma-Aldrich

SJ000025081

≥98% (HPLC)

别名:

7-(3,4-Dimethoxyphenyl)-4-(2-fluorophenyl)-1,4,5,6,7,8-hexahydro-2-methyl-5-oxo-3-quinolinecarboxylic acid propyl ester

登录查看公司和协议定价

选择尺寸


关于此项目

经验公式(希尔记法):
C28H30FNO5
化学文摘社编号:
分子量:
479.54
MDL编号:
UNSPSC代码:
12352200
PubChem化学物质编号:
NACRES:
NA.77
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

方案

≥98% (HPLC)

表单

powder

颜色

pale yellow

溶解性

DMSO: ≥40 mg/mL

储存温度

2-8°C

SMILES字符串

CCCOC(=O)C1=C(C)NC2=C(C1c3ccccc3F)C(=O)CC(C2)c4ccc(OC)c(OC)c4

InChI

1S/C28H30FNO5/c1-5-12-35-28(32)25-16(2)30-21-13-18(17-10-11-23(33-3)24(15-17)34-4)14-22(31)27(21)26(25)19-8-6-7-9-20(19)29/h6-11,15,18,26,30H,5,12-14H2,1-4H3

InChI key

JYAOIVVCGRSAFZ-UHFFFAOYSA-N

应用

SJ000025081 may be used in studies related to malarial parasite and immune signaling.

生化/生理作用

SJ000025081 is a dihydropyridine effective against Plasmodium yoelii.1,2
SJ000025081 is an antimalarial compound that inhibit the growth of asexual blood-stage P. falciparum in cultured red blood cells.
SJ000025081 is an antimalarial compound.

象形图

Skull and crossbonesEnvironment

警示用语:

Danger

危险声明

预防措施声明

危险分类

Acute Tox. 3 Oral - Aquatic Acute 1 - Aquatic Chronic 1

储存分类代码

6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

法规信息

新产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Brian T Grimberg et al.
Pharmaceuticals (Basel, Switzerland), 4(5), 681-712 (2011-06-01)
The number of available and effective antimalarial drugs is quickly dwindling. This is mainly because a number of drug resistance-associated mutations in malaria parasite genes, such as crt, mdr1, dhfr/dhps, and others, have led to widespread resistance to all known
W Armand Guiguemde et al.
Chemistry & biology, 19(1), 116-129 (2012-01-31)
Malaria, a devastating infectious disease caused by Plasmodium spp., leads to roughly 655,000 deaths per year, mostly of African children. To compound the problem, drug resistance has emerged to all classical antimalarials and may be emerging for artemisinin-based combination therapies.

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持